NW Kinetics Report issue

For profit Phase 1
Founded: Tacoma WA United States (1995)
Status: Acquired by Charles River (2006)

Organization Overview

First Clinical Trial
2006
NCT00343148
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 1 Trials (3)

avi-4020 (1 trial)

avi-4065 (1 trial)

avi-4126 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Encephalitis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 3